Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus

Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus

Introduction. Respiratory syncytial virus (RSV) is the most common pathogen causing lower respiratory tract infections in children. RSV also poses a serious threat to the elderly and immunocompromised patients. Developing a therapy based on recombinant human antibodies to block the RSV fusion (F) gl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sergey A. Klotchenko, Ekaterina A. Romanovskaya-Romanko, Marina A. Plotnikova, Anastasia A. Pulkina, Aram A. Shaldzhyan, Dmitry S. Balabashin, Victoria A. Toporova, Teimur K. Aliev, Natalia E. Gyulikhandanova, Dmitry A. Lioznov
Format:	Article
Language:	Russian
Published:	Central Research Institute for Epidemiology 2024-12-01
Series:	Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:	therapeutic monoclonal antibodies respiratory syncytial virus fusion (f) glycoprotein neutralization assay cho cell line for recombinant antibodies production vero cells
Online Access:	https://microbiol.crie.ru/jour/article/viewFile/18697/1548
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of a stable eukaryotic strain producing fully human monoclonal antibody on the basis of the human antibody against ectromelia virus
by: A. L. Matveev, et al.
Published: (2018-01-01)

A cell-penetrating bispecific antibody suppresses hepatitis B virus replication and secretion
by: Chongwei Xie, et al.
Published: (2025-03-01)

Serological cross-reactivity between Crimean-Congo haemorrhagic fever virus and Nairobi sheep disease virus glycoprotein C
by: Emmanuel A. Maze, et al.
Published: (2025-01-01)

Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
by: Jennifer L. Schwedler, et al.
Published: (2024-12-01)

Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
by: W. van der Wulp, et al.
Published: (2024-12-01)

Investigation of the effıciency of pomegranate (punica granatum l.) peel extract on herpes simplex virus-1
by: Irmak Dik, et al.
Published: (2022-06-01)

Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus
by: Shreya Mukhopadhyay, et al.
Published: (2025-01-01)

Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge
by: M. Biddle, et al.
Published: (2024-12-01)

Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China
by: Li Li, et al.
Published: (2025-12-01)

Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice
by: Anna-Polina Shurygina, et al.
Published: (2025-01-01)

T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics
by: Ruoxuan Sun, et al.
Published: (2024-12-01)

Construction of a Vero cell line expression human KREMEN1 for the development of CVA6 vaccines
by: Dongqing Zhang, et al.
Published: (2025-01-01)

Cost-savings and health impact of strategies for prevention of Respiratory Syncytial Virus with nirsevimab in Chile based on the integrated analysis of 2019–2023 national databases: A retrospective study
by: Denis Sauré, et al.
Published: (2025-04-01)

Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024-12-01)

Morphological features of autoimmune gastritis
by: Ye. A. Losik, et al.
Published: (2014-07-01)

CULTURAL PROPERTIES OF BOVINE RESPIRATORY SYNCYTIAL VIRUS STRAIN AB1908
by: V. V. Kirpichenko, et al.
Published: (2019-12-01)

A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
by: Gerhard Frey, et al.
Published: (2024-12-01)

ANALYSIS OF DOMAIN SPECIFICITY OF THE PROTECTIVE CHIMERIC ANTIBODY ch14D5a AGAINST GLYCOPROTEIN E OF TICK-BORNE ENCEPHALITIS VIRUS
by: I. K. Baykov, et al.
Published: (2018-07-01)

Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review
by: Joseph Sassine, et al.
Published: (2025-01-01)

Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01)

Editorial: Tuberculosis and humoral immunity
by: Taru S. Dutt, et al.
Published: (2025-02-01)

Association of anti-phospholipid antibodies and hepatitis B virus infection in Najaf Governorate
by: Ameer Mohammed Kadhim, et al.
Published: (2024-01-01)

Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response
by: Gabriel L. Costa, et al.
Published: (2025-12-01)

The effect of differences in the third domain of the glycoprotein E of tick-borne encephalitis virus of the Far Eastern, Siberian and European subtypes on the binding of recombinant D3 proteins with a chimeric antibody
by: I. K. Baykov, et al.
Published: (2019-05-01)

Evaluation of Recombinant Antibody Production Efficiency in CHO Cells with Sleeping Beauty Transposon Vector System
by: Pelin Kolçak Yaşlı, et al.
Published: (2024-09-01)

Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies
by: Wen-Ting K. Tsai, et al.
Published: (2024-12-01)

Bispecific antibodies and CLEM: an analytical approach to advanced cell imaging for therapeutic strategies
by: Han-ul Kim, et al.
Published: (2025-01-01)

A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins
by: Eilyn R. Lacy, et al.
Published: (2025-01-01)

Comparative Analysis of Hemagglutination Inhibition and Plaque Reduction Neutralization Tests for Japanese Encephalitis Virus Antibody Detection
by: Cui Li, et al.
Published: (2025-01-01)

Problems of creating antibody phage libraries and their solutions
by: V. S. Aripov, et al.
Published: (2024-04-01)

Inactivation of Zika Virus with Hydroxypropyl-Beta-Cyclodextrin
by: Cory R. Hewitt, et al.
Published: (2025-01-01)

Electrostatic properties of human germlines and biodistribution of small biologics
by: Leticia Maria De Souza Cordeiro, et al.
Published: (2024-12-01)

Clinical significance of establishing a red blood cell alloantibody detection database
by: XIAO Xiao, et al.
Published: (2025-01-01)

Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
by: Rahul Navab, et al.
Published: (2025-01-01)

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01)

Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01)

Scale-up of CHO cell cultures: from 96-well-microtiter plates to stirred tank reactors across three orders of magnitude
by: Anne Neuss, et al.
Published: (2025-01-01)

Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies
by: Ugochi Ebinama, et al.
Published: (2025-01-01)

Development of the immunoenzyme test system for detection of antibodies against avian leukosis virus
by: S. P. Lazareva, et al.
Published: (2018-04-01)

Preparation and application of porcine broadly neutralizing monoclonal antibodies in an immunoassay for efficiently detecting neutralizing antibodies against foot-and-mouth disease virus serotype O
by: Yimei Cao, et al.
Published: (2025-02-01)